Bortezomib in Treating Patients With Metastatic or Recurrent Colorectal Cancer
This study has been completed.
Princess Margaret Hospital, Canada
Information provided by:
National Cancer Institute (NCI)
First received: January 24, 2003
Last updated: July 23, 2008
Last verified: December 2003
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been completed.|
|Estimated Study Completion Date:||No date given|
|Estimated Primary Completion Date:||No date given|
Mackay H, Hedley D, Major P, Townsley C, Mackenzie M, Vincent M, Degendorfer P, Tsao MS, Nicklee T, Birle D, Wright J, Siu L, Moore M, Oza A. A phase II trial with pharmacodynamic endpoints of the proteasome inhibitor bortezomib in patients with metastatic colorectal cancer. Clin Cancer Res. 2005 Aug 1;11(15):5526-33.